Validation and quality control of protein microarray-based analytical methods
- PMID: 18095188
- DOI: 10.1007/s12033-007-0066-5
Validation and quality control of protein microarray-based analytical methods
Abstract
Protein microarray technology is used mainly in the research laboratory and it is being used to uncover important diagnostic and prognostic markers that may one day emerge as routine clinical laboratory tests. It is important that these methods are subject to control procedures, in order to ensure that data of the highest quality are obtained. If quality is not controlled, the assay may yield erroneous results that would mask or confound meaningful diagnostic or prognostic associations. This chapter surveys the range of strategies designed to assure the analytical quality of protein microarray methods and it also highlights some of the potential pitfalls when moving these arrays into routine clinical practice. With the development of appropriate quality control and assurance measures, we anticipate protein microarray-based assays will be of substantial benefit in the future practice of laboratory medicine.
Similar articles
-
Tissue microarrays: emerging standard for biomarker validation.Curr Opin Biotechnol. 2008 Feb;19(1):19-25. doi: 10.1016/j.copbio.2007.10.009. Epub 2007 Dec 3. Curr Opin Biotechnol. 2008. PMID: 18053705 Review.
-
Estimation and control of multiple testing error rates for microarray studies.Brief Bioinform. 2006 Mar;7(1):25-36. doi: 10.1093/bib/bbk002. Brief Bioinform. 2006. PMID: 16761362 Review.
-
Validation and quality control of protein microarray-based analytical methods.Methods Mol Med. 2005;114:233-55. doi: 10.1385/1-59259-923-0:233. Methods Mol Med. 2005. PMID: 16156108
-
Propagating uncertainty in microarray data analysis.Brief Bioinform. 2006 Mar;7(1):37-47. doi: 10.1093/bib/bbk003. Brief Bioinform. 2006. PMID: 16761363 Review.
-
Reproducible and reliable microarray results through quality control: good laboratory proficiency and appropriate data analysis practices are essential.Curr Opin Biotechnol. 2008 Feb;19(1):10-8. doi: 10.1016/j.copbio.2007.11.003. Epub 2007 Dec 26. Curr Opin Biotechnol. 2008. PMID: 18155896 Review.
Cited by
-
Antibody profiling with protein antigen microarrays in early stage cancer.Expert Opin Med Diagn. 2012 May;6(3):187-96. doi: 10.1517/17530059.2012.672969. Epub 2012 Mar 22. Expert Opin Med Diagn. 2012. PMID: 23480685 Free PMC article.
-
Improved reproducibility of reverse-phase protein microarrays using array microenvironment normalization.Proteomics. 2009 Dec;9(24):5562-6. doi: 10.1002/pmic.200900505. Proteomics. 2009. PMID: 19834915 Free PMC article.
-
Review of the Use of Liquid Chromatography-Tandem Mass Spectrometry in Clinical Laboratories: Part II-Operations.Ann Lab Med. 2022 Sep 1;42(5):531-557. doi: 10.3343/alm.2022.42.5.531. Ann Lab Med. 2022. PMID: 35470272 Free PMC article. Review.
-
Protein microarrays for personalized medicine.Clin Chem. 2010 Mar;56(3):376-87. doi: 10.1373/clinchem.2009.137158. Epub 2010 Jan 14. Clin Chem. 2010. PMID: 20075183 Free PMC article. Review.
-
Quality control, analysis and secure sharing of Luminex® immunoassay data using the open source LabKey Server platform.BMC Bioinformatics. 2013 Apr 30;14:145. doi: 10.1186/1471-2105-14-145. BMC Bioinformatics. 2013. PMID: 23631706 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources